Sharay Setti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesMark littonSharay settiHans moebiusRachel leningtonSherif redaAthira pharmaJulie rathbunAlzheimer association international congressMotor neurone disease associationSociety for neuroscience sfn annual meetingSecurities exchangeInternational symposiumExchange commissionClinical development pipeline programsDevelopment rd expenses

Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer s Disease Seite 1

15.11.2023 - Data presented at Society for Neuroscience Annual Meeting 2023BOTHELL, Wash., Nov. 15, 2023 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore . Seite 1

United statesSharay settiAthira pharmaSociety for neuroscience annual meetingAthira pharma incSociety for neuroscience sfn annual meetingKevin churchNeuroscience annual meetingAnnual meetingChief scientific officerSmall molecule positive modulatorProtects against amyloidPathological alterationsDisease models in vitroSenior scientistAthira pharma chart

Athira Pharma Reports Third Quarter 2023 Financial Results and Pipeline and Business Updates

Continues to report clinical and preclinical findings supporting the potential benefits of its small molecule therapeutic candidates targeting the.

United statesJulie rathbunSharay settiMark littonAthira pharmaWei wuWaltere washington convention centerDrug administrationDevelopment of novel therapies for neurodegenerativeSociety for neuroscienceClinical development pipeline programsSecurities exchangeAlzheimer association international conferenceAthira pharma incDevelopment rd expensesExchange commission

Athira Pharma to Present Data Supporting Therapeutic Potential of Enhancing HGF/MET Neurotrophic System at Upcoming Scientific Conferences

06.03.2023 - BOTHELL, Wash., March 06, 2023 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that . Seite 1

Vastra gotalands lanAthira pharmaWei wuSharay settiAnne berthiaumeAthira pharma incAmerican society for experimental neurotherapeuticsKevin churchInternational conference on alzheimerPresent data supporting therapeutic potentialUpcoming scientific conferencesAmerican societyChief scientific officerSmall molecule positive modulatorHepatocyte growth factorAmyotrophic lateral